标题
Rituximab biosimilars in clinical practice
作者
关键词
-
出版物
LEUKEMIA & LYMPHOMA
Volume 61, Issue 7, Pages 1523-1524
出版商
Informa UK Limited
发表日期
2020-07-06
DOI
10.1080/10428194.2020.1788016
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The clinical outcomes of rituximab biosimilar CT-P10 (Truxima®) with CHOP as first-line treatment for patients with diffuse large B-cell lymphoma: real-world experience
- (2020) Kyoungmin Lee et al. LEUKEMIA & LYMPHOMA
- Top companies and drugs by sales in 2019
- (2020) Lisa Urquhart NATURE REVIEWS DRUG DISCOVERY
- Rituximab biosimilars for lymphoma in Europe
- (2019) Wojciech Jurczak et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Scientific rationale underpinning the development of biosimilar rituximab in hematological cancers and inflammatory diseases
- (2019) Wojciech Jurczak et al. Future Oncology
- Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial
- (2018) Won Park et al. mAbs
- Safety and Immunogenicity of Rituximab Biosimilar GP2013 After Switch From Reference Rituximab in Patients With Active Rheumatoid Arthritis
- (2018) Hans-Peter Tony et al. ARTHRITIS CARE & RESEARCH
- Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial
- (2018) Michinori Ogura et al. Lancet Haematology
- Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study
- (2017) Wojciech Jurczak et al. Lancet Haematology
- Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial
- (2017) Won Seog Kim et al. Lancet Haematology
- A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis
- (2016) Dae Hyun Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- Key considerations in the preclinical development of biosimilars
- (2015) Lynne A. Bui et al. DRUG DISCOVERY TODAY
- Clinical trial development for biosimilars
- (2015) Rieke Alten et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars
- (2012) Steven A. Berkowitz et al. NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started